Date: February 22, 2018 Source: Society for the Study of Addiction Summary: Two papers published today look at the current evidence of the effects of medical marijuana laws and conclude there is little support that such laws increase recreational marijuana use among adolescents or reduce opioid overdose deaths.
In 1996, California became the first US state to legalise marijuana use for medical purposes. Medical marijuana is now legal in 29 states. Opponents of medical marijuana argue that such laws increase recreational marijuana use among adolescents, while advocates contend that medical marijuana helps to address the US opioid crisis by reducing overdose deaths.
Two papers published today in the scientific journal Addiction look at the current evidence of the effects of medical marijuana laws and conclude that there is little support for either claim.
The first claim, that legalizing medical marijuana increases recreational use among adolescents, is addressed by a new meta-analysis that pooled the results of eleven separate studies of data from four large-scale US surveys dating back as far as 1991. Results of the meta-analysis indicate that no significant changes (increases or decreases) occurred in adolescent recreational use following enactment of medical marijuana laws. Far fewer studies examined the effects of medical marijuana laws among adults, although existing evidence suggests that adult recreational use may increase after medical marijuana laws are passed
Senior author Professor Deborah Hasin says, "Although we found no significant effect on adolescent marijuana use, we may find that the situation changes as commercialized markets for medical marijuana develop and expand, and as states legalize recreational marijuana use. However, for now, there appears to be no basis for the argument that legalising medical marijuana increases teens' use of the drug."
The second claim, that legalising medical marijuana reduces opioid overdose deaths by offering a less risky method of pain management, is addressed in an editorial co-authored by several members of Addiction's editorial board. Here, the evidence is clear but weak, being rooted in ecological studies whose results have not been confirmed through more rigorous methods. Although those studies show a correlation over time between the passage of medical marijuana laws and opioid overdose death rates, they do not provide any evidence that the laws caused the reduction in deaths. In fact, several recent studies have shown that chronic pain patients who use cannabis do not use lower doses of opioids. There are more plausible reasons for the reduction in opioid deaths that ought to be investigated.
Story Source:
Materials provided by Society for the Study of Addiction. Note: Content may be edited for style and length.
Journal References:
Sarvet AL, Wall MM, Fink DS, Greene E, Le A, Boustead AE, Pacula RL, Keyes KM, Cerda M, Galea S, and Hasin DS. Medical marijuana laws and adolescent marijuana use in the United States: A systematic review and meta-analysis. Addiction, 2018; DOI: 10.1111/add.14136
Wayne Hall, Robert West, John Marsden, Keith Humphreys, Jo Neale, Nancy Petry. It is premature to expand access to medicinal cannabis in hopes of solving the US opioid crisis. Addiction, 2018; DOI: 10.1111/add.14139
Cite This Page:
Society for the Study of Addiction. "Experts challenge claims about medical marijuana's impact on teen recreational use and opioid deaths." ScienceDaily. ScienceDaily, 22 February 2018. <www.sciencedaily.com/releases/2018/02/180222090343.htm>.
Nenhum comentário:
Postar um comentário